[1]
de Andrade Neto, J.B. et al. 2022. Virtual screening based on molecular docking of lysosomotropic compounds as therapeutic agents for COVID-19. Journal of Health & Biological Sciences. 10, 1 (jun. 2022), 1–12. DOI:https://doi.org/10.12662/2317-3076jhbs.v10i1.4238.p1-12.2022.